BlossomHill Therapeutics Inc (BLSM) Stock Price, Quote, News & History

BLSMNASDAQ
$16.46
0.362.26%
Last update: Aug 19, 9:47 AM

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-56.89M
Investing Cash Flow (TTM)
-678.00K
Financing Cash Flow (TTM)
84.76M
Free Cash Flow (TTM)
-57.56M
Capital Expenditure (TTM)
-678.00K
Net Change in Cash (TTM)
27.20M

Valuation Metrics

Enterprise Value
$377.55M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-21.08%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-$5.23

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$116.00M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$16.21
Close
-
Volume / Avg.
12.36K / 522.16K
Day Range
$16.16 - $16.50
52 Wk Range
15.25 - 17.25
Market Cap
$478.81M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
-
Short Interest
-
Days to Cover
-

About

Sector
N/A
Industry
N/A
BlossomHill Therapeutics Inc is a clinical-stage biopharmaceutical company applying its intentional, chemistry-based approach to develop small molecule medicines that address unmet medical needs in cancer treatment. Its product pipeline includes two ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy BlossomHill Therapeutics (BLSM) stock?

A

You can purchase shares of BlossomHill Therapeutics (NASDAQ:BLSM) through any online brokerage.

View our list of the best stock brokerages

Q

Who are BlossomHill Therapeutics (BLSM) competitors?

A

There are no as such competitors for BlossomHill Therapeutics.

Q

What is the forecast, or price target, for BlossomHill Therapeutics (BLSM) stock?

A

There is no analysis for BlossomHill Therapeutics to provide a consensus price target.

Q

What is the current price for BlossomHill Therapeutics (BLSM)?

A

The stock price for BlossomHill Therapeutics (NASDAQ: BLSM) is $16.4646 last updated August 19, 2026 at 9:47 AM EDT.

Q

Does BlossomHill Therapeutics (BLSM) pay a dividend?

A

There are no upcoming dividends for BlossomHill Therapeutics.

Q

When is BlossomHill Therapeutics (NASDAQ:BLSM) reporting earnings?

A

BlossomHill Therapeutics does not have any upcoming earnings scheduled.

Q

Is BlossomHill Therapeutics (BLSM) going to split?

A

There is no upcoming split for BlossomHill Therapeutics.

Q

What sector and industry does BlossomHill Therapeutics (BLSM) operate in?

A

BlossomHill Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.